ARDS, Human Clinical Trial
Official title:
Effect of Electric Impedance Tomography-Guided PEEP Titration on the Ventilation-perfusion Mismatch in Moderate or Severe ARDS
Verified date | June 2024 |
Source | Southeast University, China |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Acute respiratory syndrome distress (ARDS) is a clinical common syndrome with high mortality. Mechanical ventilation (MV) is the cornerstone of management of ARDS but can lead to ventilator-induced lung injury. Positive end-expiratory pressure (PEEP), as one of main component of MV, has been widely used in the clinical practice. However, how to best set PEEP is still a difficult problem for moderate to severe ARDS patients. EIT, an imaging tool evaluating the regional ventilation distribution at the bedside, can achieve the individual PEEP selection for all mechanically ventilated patients. This article compared the effect of PEEP titrated guided by EIT with fraction of inspired oxygen (FiO2)-PEEP table on the ventilation-perfusion mismatch.
Status | Completed |
Enrollment | 69 |
Est. completion date | May 30, 2024 |
Est. primary completion date | May 30, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: 1. Intubated patients with moderate and severe ARDS (Berlin definition, PaO2/FiO2 =200 mmHg at PEEP 5 cmH2O) 2. undergoing deep sedation on controlled mechanical ventilation within72 hours after ARDS onset Exclusion Criteria: 1. age <18 years old 2. patient undergoing legal protection 3. contra-indications to EIT (e. g. severe chest trauma or wounds) 4. pneumothorax 5. patient undergoing ECMO 6. pregnancy |
Country | Name | City | State |
---|---|---|---|
China | Zhongda Hospital, School of Medicine, Southeast University | Nanjing | Jiangsu |
Lead Sponsor | Collaborator |
---|---|
Southeast University, China |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Difference in ventilation-perfusion mismatch between EIT-PEEP, low-PEEP, and high PEEP | EIT-PEEP was obtained by EIT, low-PEEP was obtained by low FIO2-PEEP table, and high-PEEP was obtained by high FIO2-PEEP table. | up to 24 hours | |
Secondary | difference in center of ventilation (COV) between EIT-PEEP, low-PEEP, and high PEEP | COV was obtained by EIT monitoring | up to 24 hours | |
Secondary | Difference in dead space measured with EIT between EIT-PEEP, low-PEEP, and high PEEP | dead space was obtained by EIT monitoring | up to 24 hours | |
Secondary | Difference in shunt measured with EIT between EIT-PEEP, low-PEEP, and high PEEP | shunt was obtained by EIT monitoring | up to 24 hours | |
Secondary | Difference in wasted ventilation measured with EIT between EIT-PEEP, low-PEEP, and high PEEP | wasted ventilation was obtained by EIT monitoring | up to 24 hours | |
Secondary | Difference in wasted perfusion measured with EIT between EIT-PEEP, low-PEEP, and high PEEP | wasted perfusion was obtained by EIT monitoring | up to 24 hours | |
Secondary | ventilation distribution measured with EIT between EIT-PEEP, low-PEEP, and high PEEP | ventilation distribution was obtained by EIT in difference regions | up to 24 hours | |
Secondary | perfusion distribution measured with EIT between EIT-PEEP, low-PEEP, and high PEEP | perfusion distribution was obtained by EIT in difference regions | up to 24 hours | |
Secondary | Correlations between ventilation-perfusion mismatch and overdistension and lung collapses | Overdistension (%) and lung collapses (%) will be assessed by EIT. These two values cannot be measured separately. V/Q mismatch will be computed by EIT, and expressed in %. Correlation will be performed by linear regression. | up to 24 hours | |
Secondary | recruitment-to-inflation (R/I) ratio | recruitment-to-inflation (R/I) ratio was computed between the two PEEP levels | up to 24 hours | |
Secondary | PaO2/FIO2 | PaO2/FIO2 was obtained by gas analysis | up to 24 hours | |
Secondary | respiratory system mechanics | respiratory system compliance included lung compliance, chest wall compliance, and respiratory system compliance. respiratory system resistance will be computed as the inverse of compliance. | up to 24 hours | |
Secondary | Correlation between V/Q mismatch markers and recruitability | Recruitability will be assessed between 15 and 5 cmH2O by respiratory mechanics, as the recruited volumes value (in mL). R/I ratio will be derived from these data (no unit). V/Q mismatch will be computed by EIT, and expressed in %. Correlation will be performed by linear regression. | up to 24 hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06444750 -
Comparison of the Proteome in ICU Patients in Search for TRALI Biomarkers
|
||
Not yet recruiting |
NCT05306392 -
Effects of Induced Moderate Hypothermia on ARDS Patients Under Venovenous ExtraCorporeal Membrane Oxygenation
|
N/A | |
Terminated |
NCT04954014 -
Pilot Study of Single Dose Bevacizumab as Treatment for Acute Respiratory Distress Syndrome (ARDS) in COVID-19 Patients
|
Phase 2 | |
Completed |
NCT04719182 -
Practice of Adjunctive Treatments in Intensive Care Unit Patients With COVID-19
|
||
Completed |
NCT04274296 -
Advisory Lead ARDS Respirator Management
|
||
Recruiting |
NCT03215316 -
Screening Expiratory Flow Limitation by Flow-time Curve
|
N/A | |
Recruiting |
NCT04115514 -
Treatment of ARDS With Instilled T3
|
Phase 2 | |
Not yet recruiting |
NCT05061212 -
The Mechanism of Extracellular Vesicles Containing Mitochondrial DNA in ARDS Lung Injury Caused by Extrapulmonary Sepsis
|
||
Completed |
NCT05693051 -
Use of Prone Position Ventilation in Danish Patients With COVID-19 Induced Severe ARDS Treated With VV-ECMO
|
||
Not yet recruiting |
NCT04556864 -
Hemodynamic Impact on Critical Care Patients With Lung Damage Secondary to COVID-19
|
||
Recruiting |
NCT04174014 -
Optimal PEEP Titration Combining Transpulmonary Pressure Measurement and Electric Impedance Tomography
|
N/A | |
Enrolling by invitation |
NCT06164639 -
Potential Biomarkers for Reflux Aspiration-induced Lung Injury.
|
||
Terminated |
NCT05384379 -
Efficacy and Safety Evaluation of BZ371B in ARDS Patients
|
Early Phase 1 | |
Completed |
NCT04375735 -
London's Exogenous Surfactant Study for COVID19
|
Phase 1/Phase 2 | |
Completed |
NCT06224010 -
Respiratory Drive and Inspiratory Effort in COVID-19 Associated ARDS
|
||
Not yet recruiting |
NCT04530188 -
Effects of Sevoflurane on Extravascular Lung Water and Pulmonary Vascular Permeability in Patients With ARDS
|
Phase 3 | |
Completed |
NCT03405038 -
Prone Position Impact in ARDS Patients on the Incidence of Central Venous Catheter Colonization
|
||
Recruiting |
NCT05148026 -
Regional Citrate Anticoagulation for RRT During V-V ECMO
|
N/A | |
Recruiting |
NCT04390360 -
Smartphone Application for Initiation of Protective Ventilation. Clinical Impact of Instrumental Dead Space Reduction
|
N/A | |
Completed |
NCT06197256 -
Cardiac Dysfunction in Critically Ill Covid-19 Patients
|